Cargando…
Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study
PURPOSE: Vitamin D pathway single nucleotide polymorphisms (SNPs) are potentially useful proxies for investigating whether circulating vitamin D metabolites [total 25-hydroxyvitamin-D, 25(OH)D; 1,25-dihydroxyvitamin, 1,25(OH)(2)D] are causally related to prostate cancer. We investigated associations...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298668/ https://www.ncbi.nlm.nih.gov/pubmed/25488826 http://dx.doi.org/10.1007/s10552-014-0500-5 |
_version_ | 1782353275992932352 |
---|---|
author | Gilbert, Rebecca Bonilla, Carolina Metcalfe, Chris Lewis, Sarah Evans, David M. Fraser, William D. Kemp, John P. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Lane, J. Athene Smith, George Davey Lathrop, Mark Martin, Richard M. |
author_facet | Gilbert, Rebecca Bonilla, Carolina Metcalfe, Chris Lewis, Sarah Evans, David M. Fraser, William D. Kemp, John P. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Lane, J. Athene Smith, George Davey Lathrop, Mark Martin, Richard M. |
author_sort | Gilbert, Rebecca |
collection | PubMed |
description | PURPOSE: Vitamin D pathway single nucleotide polymorphisms (SNPs) are potentially useful proxies for investigating whether circulating vitamin D metabolites [total 25-hydroxyvitamin-D, 25(OH)D; 1,25-dihydroxyvitamin, 1,25(OH)(2)D] are causally related to prostate cancer. We investigated associations of sixteen SNPs across seven genes with prostate-specific antigen-detected prostate cancer. METHODS: In a nested case–control study (within the ProtecT trial), we estimated odds ratios and 95 % confidence intervals (CIs) quantifying associations between SNPs and prostate cancer. Subgroup analyses investigated whether associations were stronger in men who had high/low sun exposure [a proxy for 25(OH)D]. We quantified associations of SNPs with stage (T1–T2/T3–T4) and grade (<7/≥7). Multiple variant scores included SNPs encoding proteins involved in 25(OH)D synthesis and metabolism. RESULTS: We included 1,275 prostate cancer cases (141 locally advanced, 385 high grades) and 2,062 healthy controls. Vitamin D-binding protein SNPs were associated with prostate cancer (rs4588-A: OR 1.20, CI 1.01, 1.41, p = 0.04; rs7041-T: OR 1.19, CI 1.02, 1.38, p = 0.03). Low 25(OH)D metabolism score was associated with high (vs low) grade (OR 0.76, CI 0.63, 0.93, p = 0.01); there was a similar association of its component variants: rs6013897-A in CYP24A1 (OR 0.78, CI 0.60, 1.01, p = 0.06) and rs10877012-T in CYP27B1 (OR 0.80, CI 0.63, 1.02, p = 0.07). There was no evidence that associations differed by level of sun exposure. CONCLUSION: We found some evidence that vitamin D pathway SNPs were associated with prostate cancer risk and grade, but not stage. There was no evidence of an association in men with deficient vitamin D (measured by having low sun exposure). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10552-014-0500-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4298668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-42986682015-01-23 Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study Gilbert, Rebecca Bonilla, Carolina Metcalfe, Chris Lewis, Sarah Evans, David M. Fraser, William D. Kemp, John P. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Lane, J. Athene Smith, George Davey Lathrop, Mark Martin, Richard M. Cancer Causes Control Original Paper PURPOSE: Vitamin D pathway single nucleotide polymorphisms (SNPs) are potentially useful proxies for investigating whether circulating vitamin D metabolites [total 25-hydroxyvitamin-D, 25(OH)D; 1,25-dihydroxyvitamin, 1,25(OH)(2)D] are causally related to prostate cancer. We investigated associations of sixteen SNPs across seven genes with prostate-specific antigen-detected prostate cancer. METHODS: In a nested case–control study (within the ProtecT trial), we estimated odds ratios and 95 % confidence intervals (CIs) quantifying associations between SNPs and prostate cancer. Subgroup analyses investigated whether associations were stronger in men who had high/low sun exposure [a proxy for 25(OH)D]. We quantified associations of SNPs with stage (T1–T2/T3–T4) and grade (<7/≥7). Multiple variant scores included SNPs encoding proteins involved in 25(OH)D synthesis and metabolism. RESULTS: We included 1,275 prostate cancer cases (141 locally advanced, 385 high grades) and 2,062 healthy controls. Vitamin D-binding protein SNPs were associated with prostate cancer (rs4588-A: OR 1.20, CI 1.01, 1.41, p = 0.04; rs7041-T: OR 1.19, CI 1.02, 1.38, p = 0.03). Low 25(OH)D metabolism score was associated with high (vs low) grade (OR 0.76, CI 0.63, 0.93, p = 0.01); there was a similar association of its component variants: rs6013897-A in CYP24A1 (OR 0.78, CI 0.60, 1.01, p = 0.06) and rs10877012-T in CYP27B1 (OR 0.80, CI 0.63, 1.02, p = 0.07). There was no evidence that associations differed by level of sun exposure. CONCLUSION: We found some evidence that vitamin D pathway SNPs were associated with prostate cancer risk and grade, but not stage. There was no evidence of an association in men with deficient vitamin D (measured by having low sun exposure). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10552-014-0500-5) contains supplementary material, which is available to authorized users. Springer International Publishing 2014-12-09 2015 /pmc/articles/PMC4298668/ /pubmed/25488826 http://dx.doi.org/10.1007/s10552-014-0500-5 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Paper Gilbert, Rebecca Bonilla, Carolina Metcalfe, Chris Lewis, Sarah Evans, David M. Fraser, William D. Kemp, John P. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Lane, J. Athene Smith, George Davey Lathrop, Mark Martin, Richard M. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study |
title | Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study |
title_full | Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study |
title_fullStr | Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study |
title_full_unstemmed | Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study |
title_short | Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study |
title_sort | associations of vitamin d pathway genes with circulating 25-hydroxyvitamin-d, 1,25-dihydroxyvitamin-d, and prostate cancer: a nested case–control study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298668/ https://www.ncbi.nlm.nih.gov/pubmed/25488826 http://dx.doi.org/10.1007/s10552-014-0500-5 |
work_keys_str_mv | AT gilbertrebecca associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT bonillacarolina associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT metcalfechris associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT lewissarah associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT evansdavidm associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT fraserwilliamd associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT kempjohnp associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT donovanjennyl associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT hamdyfreddiec associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT nealdavide associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT lanejathene associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT smithgeorgedavey associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT lathropmark associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy AT martinrichardm associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy |